NCT07612371 Effects of Motor Imagery and Action Observation on Motor Function in Unilateral Cerebral Palsy
| NCT ID | NCT07612371 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bahçeşehir University |
| Condition | Cerebral Palsy (CP) |
| Study Type | INTERVENTIONAL |
| Enrollment | 48 participants |
| Start Date | 2026-05-15 |
| Primary Completion | 2026-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 48 participants in total. It began in 2026-05-15 with a primary completion date of 2026-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to evaluate the effects of action observation therapy and motor imagery methods, provided in addition to a conventional physiotherapy and rehabilitation program, on gross motor function, upper and lower extremity functional skills, and quality of life in children with cerebral palsy.
Eligibility Criteria
Inclusion Criteria: * Being between 7 and 16 years of age * Having a diagnosis of unilateral cerebral palsy made by a pediatric neurologist * Being classified at levels I-II of the Gross Motor Function Classification System (GMFCS) * Scoring above 24 on the Mini-Mental State Examination for Children * Having no cognitive impairments (i.e., possessing an appropriate cognitive level to follow task instructions) * Willingness to participate in the study (child and family) * Being classified at levels I-III of the Manual Ability Classification System (MACS) -Being classified at levels I-III of the Communication Function Classification System (CFCS) - Exclusion Criteria: * Children with uncontrolled seizures * Children who have received motor imagery training or action observation therapy within the last 6 months * Children with contractures * Children with severe visual and/or hearing impairments * Being classified at levels III, IV, or V according to the GMFCS * Scoring below 24 on the Mini-Mental State Examination for Children * Being classified at levels IV-V of the Manual Ability Classification System (MACS) * Having undergone orthopedic surgery or botulinum toxin (Botox) treatment within the last 6 months
Contact & Investigator
Hasan K. Alptekin, Prof. Dr.
STUDY CHAIR
Bahçeşehir University
Frequently Asked Questions
Who can join the NCT07612371 clinical trial?
This trial is open to participants of all sexes, aged 7 Years or older, up to 16 Years, studying Cerebral Palsy (CP). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07612371 currently recruiting?
Yes, NCT07612371 is actively recruiting participants. Contact the research team at betul.unal1@bahcesehir.edu.tr for enrollment information.
Where is the NCT07612371 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07612371 clinical trial?
NCT07612371 is sponsored by Bahçeşehir University. The principal investigator is Hasan K. Alptekin, Prof. Dr. at Bahçeşehir University. The trial plans to enroll 48 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.